{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:58:13Z","timestamp":1786982293590,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12185-009-0368-4","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T00:39:20Z","timestamp":1246235960000},"page":"230-234","source":"Crossref","is-referenced-by-count":10,"title":["A chronic myeloid leukemia patient with atypical karyotype and BCR\u2013ABL e13a3 transcript caused by complex chromosome rearrangement"],"prefix":"10.1007","volume":"90","author":[{"given":"Masayoshi","family":"Masuko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Toba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550\u20134.","journal-title":"Nature"},{"key":"368_CR2","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deiningger","year":"2000","unstructured":"Deiningger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2002-03-0930","volume":"100","author":"HK Al-Ali","year":"2002","unstructured":"Al-Ali HK, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MW. CML with an e1a3 BCR\u2013ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 2002;100:1092\u20133.","journal-title":"Blood"},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ajh.10429","volume":"74","author":"LG Liu","year":"2003","unstructured":"Liu LG, Tanaka H, Ito K, Kyo T, Ito T, Kimura A. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR\u2013ABL transcript having a DNA breakpoint between ABL exons a2 and a3. Am J Hematol. 2003;74:268\u201372.","journal-title":"Am J Hematol"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ajh.10456","volume":"75","author":"DS Snyder","year":"2004","unstructured":"Snyder DS, McMahon R, Cohen SR, Slovak ML. Chronic myeloid leukemia with e13a3 BCR\u2013ABL fusion: benign course responsive to imatinib with an RT-PCR advisory. Am J Hematol. 2004;75:92\u20135.","journal-title":"Am J Hematol"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cancergencyto.2006.11.021","volume":"174","author":"B Pienkowska-Grela","year":"2007","unstructured":"Pienkowska-Grela B, Woroniecka R, Solarska I, Kos K, Pastwi\u0144ska A, Konopka L, et al. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR\u2013ABL b2a3 transcript. Cancer Genet Cytogenet. 2007;174:111\u20135.","journal-title":"Cancer Genet Cytogenet"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Hematol. 2002;107:76\u201394.","journal-title":"Acta Hematol"},{"issue":"6","key":"368_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","volume":"108","author":"M Baccarani","year":"2006","unstructured":"Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108(6):1809\u201320.","journal-title":"Blood"},{"issue":"23","key":"368_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355(23):2408\u201317.","journal-title":"N Engl J Med"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2002-09-2763","volume":"102","author":"BJ Huntly","year":"2003","unstructured":"Huntly BJ, Guilhot F, Reid AG, Vassiliou G, Hennig E, Franke C, et al. Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. Blood. 2003;102:2205\u201312.","journal-title":"Blood"},{"issue":"6","key":"368_CR11","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1182\/blood-2004-06-2208","volume":"105","author":"A Quintas-Cardama","year":"2005","unstructured":"Quintas-Cardama A, Kantarjian H, Talpaz M, O\u2019Brien S, Garcia-Manero G, Verstovsek S, et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 2005;105(6):2281\u20136.","journal-title":"Blood"},{"issue":"2","key":"368_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.leu.2402813","volume":"17","author":"C Schoch","year":"2003","unstructured":"Schoch C, Haferlach T, Kern W, Schnittger S, Berger U, Hehlmann R, et al. Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia. 2003;17(2):461\u20133.","journal-title":"Leukemia"},{"issue":"10","key":"368_CR13","first-page":"1696","volume":"8","author":"S Iwata","year":"1994","unstructured":"Iwata S, Mizutani S, Nakazawa S, Yata J. Heterogeneity of the breakpoint in the ABL gene in cases with BCR\/ABL transcript lacking ABL exon a2. Leukemia. 1994;8(10):1696\u2013702.","journal-title":"Leukemia"},{"issue":"3","key":"368_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000064701","volume":"108","author":"IB Otaz\u00fa","year":"2002","unstructured":"Otaz\u00fa IB, Bel\u00e9n Rivero M, Ol\u00edcio R, Pinto A, Zalcberg I, Seu\u00e1nez HN. A rare, in-frame BCR\u2013ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia. Acta Haematol. 2002;108(3):150\u20133.","journal-title":"Acta Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0368-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0368-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T22:57:21Z","timestamp":1589929041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0368-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]}}}